在接受置换疗法治疗的儿童中对素刺激剂产生耐药性
Mehtap Kaya1, Neslihan Cicek1, Sercin Guven1
1Division of Pediatric Nephrology, Department of Pediatrics, School of Medicine, Marmara University, Istanbul, Turkey.
Clinical pediatrics
|December 18, 2024
概括
高水平和二次性甲状腺功能障碍症可能会导致慢性病患者接受替代疗法的儿童对红色素的耐药性,影响贫血治疗.
科学领域:
- 儿科脏病学 儿科脏病学
- 血液学 血液学 血液学
- 内分泌学 在内分泌学.
背景情况:
- 慢性病 (CKD) 中贫血很常见,通常与红色素 (EPO) 缺乏有关.
- 红素刺激剂 (ESA) 是主要的治疗方法,但红素耐药性 (ER) 是一个挑战.
- 红色素耐药性指数 (ERI) 量化了ER,这对于治疗儿科CKD患者的贫血至关重要.
研究的目的:
- 在接受代疗法 (RRT) 的儿童中识别与高红色素抵抗指数 (ERI) 相关的因素.
- 探索儿科RRT患者代谢因素和ER之间的关系.
主要方法:
- 对33名接受RRT治疗至少3个月的儿童进行了回顾性分析.
- 评估红色素耐药性指数 (ERI) 的值.
- 统计分析以确定ERI与血清,偏激素 (PTH) 和高血压之间的关联.
主要成果:
- 平均ERI为15.7IU/kg/w/g/dL. 这一平均值为15.7IU/kg/w/g/dL.
- 在血清含量和ERI之间发现了显著的正相关性 (r = 0.41,P = .016).
- 在高ERI组中观察到高的PTH水平和与高血压相关的趋势.
结论:
- 过光血症与儿科RRT患者的ERI增加显著相关.
- 二次性甲状腺功能障碍症可能在这种人群中起到对红色素耐药性的作用.
- 这些发现表明,改善晚期CKD儿童贫血管理的潜在治疗点.
相关概念视频
Renal Failure: Dose Adjustments
63
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
63
Erythropoiesis
4.0K
Red blood cells (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia,...
4.0K
Factors Affecting Renal Clearance: Renal Impairment
53
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
53
Dialysis
261
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
261
Renal Drug Excretion: Tubular Secretion
121
Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
121
Role of Hematopoietic Growth Factors
1.2K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.2K


